Nano Labs (NASDAQ:NA) has entered into an at-the-market offering agreement to sell its shares of Class A ordinary shares having an aggregate offering price of up to $45M. Net proceeds from the sale ...

OpenAI has begun rolling out GPT-5, the latest iteration of its flagship language model, to all ChatGPT users. The company’s CEO Sam Altman called GPT-5 “a significant step along the path to AGI” ...

Arduino has created a Renesas RA4M1 microcontroller board in its Nano form-factor. Called Nano R4, it follows the Uno R4, the first Arduino to use the RA4M1. “Whether you’re working on a connected ...

New York, N.Y., July 23, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on ...

New York, New York--(Newsfile Corp. - July 23, 2025) - NANO Nuclear Energy Inc. (NASDAQ: NNE) ("NANO Nuclear" or "the Company"), a leading advanced nuclear energy and technology company focused on ...

New York, N.Y., July 14, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on ...

Hi, I'm Bill. I'm a software developer with a passion for making and electronics. I do a lot of things and here is where I document my learning in order to be able to inspire other people to make ...

NANO Nuclear Energy Inc. has launched a significant two-year irradiation testing program in partnership with the Massachusetts Institute of Technology (MIT) to analyze the behavior of nitrate molten ...

Rallybio ended the RLYB212 FNAIT program after Phase 2 data showed drug levels failed to reach target concentration for efficacy. Dosing of RLYB116, Rallybio’s C5 inhibitor, starts in Q2 2025 with ...

iBio in-licensed IBIO-600 from AstralBio for $750,000 in stock, with potential milestone payments of up to $28 million. IBIO-600 showed potent myostatin inhibition in preclinical studies, with ...